Topic: University Of Western Ontario

Researchers at the University of Western Ontario have received FDA approval to begin human clinical trials for an HIV vaccine. The vaccine uses a genetically modified, killed version of the virus to trigger an immune response. Questions are raised about the ethics and methodology of testing a preventative vaccine on human subjects, particularly regarding how researchers determine its effectiveness against live infection.